schliessen

Filtern

 

Bibliotheken

Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin

Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration... Full description

Journal Title: PLoS ONE Vol.8(9), p.e73860
Main Author: Chen Zhao
Other Authors: Qiang Feng , Zengpei Dou , Wei Yuan , Chenguang Sui , Xinghua Zhang , Guimin Xia , Hongfang Sun , Jie Ma
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0073860
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: doaj_soai_doaj_org_article_3faf87b4fb964fb086bc3f90a91b56a8
title: Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin
format: Article
creator:
  • Chen Zhao
  • Qiang Feng
  • Zengpei Dou
  • Wei Yuan
  • Chenguang Sui
  • Xinghua Zhang
  • Guimin Xia
  • Hongfang Sun
  • Jie Ma
subjects:
  • Sciences (General)
ispartof: PLoS ONE, Vol.8(9), p.e73860
description: Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration was substantially improved in liver as well as a decrease in blood and other organs by spleen injection mimicking portal vein perfusion (regional administration). To further investigate the targeted therapeutic effect of galactosylated liposome encapsulated doxorubicin (Dox) by regional administration, liver targeting liposomes were prepared by incorporating galactosylated-DPPE to conventional liposomes. Liposome uptake and targeting were verified in vitro and in vivo by fluorescence microscopy and xenogen IVIS imaging system, respectively. The results showed that galactose targeted liposomes presented a stronger specific cell uptake by human hepatocellular carcinoma HepG2 cells compared to the non-targeted liposomes. In vivo fluorescence imaging showed that the intra-hepatic deposition of conventional and galactosylated liposomes via spleen injection was more than that via tail vein administration, and galactosylated liposomes had higher fluorescent intensity over conventional liposomes in the liver post spleen administration. The anti-tumor effect of various drug administration routes for both liposomal formulations was evaluated using a murine liver metastasis model of colon cancer. The results indicated that tumor progression in the liver and mesenteric lymph nodes was significantly suppressed by Dox-loaded galactosylated liposomes via spleen injection, while no significance was observed in non-targeted formulations. Our data indicated that local perfusion of galactosylated liposomal doxorubicin had a great promise for the treatment of liver metastasis from colon cancer.
language: eng
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0073860
fulltext: fulltext_linktorsrc
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID1224848024
RANK0.06999999
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidoai_doaj_org_article_3faf87b4fb964fb086bc3f90a91b56a8
sourceiddoaj_s
recordidTN_doaj_soai_doaj_org_article_3faf87b4fb964fb086bc3f90a91b56a8
sourcesystemOther
dbidDOA
pqid1431991398
galeid478321144
display
typearticle
titleLocal targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin
creatorChen Zhao ; Qiang Feng ; Zengpei Dou ; Wei Yuan ; Chenguang Sui ; Xinghua Zhang ; Guimin Xia ; Hongfang Sun ; Jie Ma
ispartofPLoS ONE, Vol.8(9), p.e73860
identifierE-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0073860
subjectSciences (General)
descriptionSince regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration was substantially improved in liver as well as a decrease in blood and other organs by spleen injection mimicking portal vein perfusion (regional administration). To further investigate the targeted therapeutic effect of galactosylated liposome encapsulated doxorubicin (Dox) by regional administration, liver targeting liposomes were prepared by incorporating galactosylated-DPPE to conventional liposomes. Liposome uptake and targeting were verified in vitro and in vivo by fluorescence microscopy and xenogen IVIS imaging system, respectively. The results showed that galactose targeted liposomes presented a stronger specific cell uptake by human hepatocellular carcinoma HepG2 cells compared to the non-targeted liposomes. In vivo fluorescence imaging showed that the intra-hepatic deposition of conventional and galactosylated liposomes via spleen injection was more than that via tail vein administration, and galactosylated liposomes had higher fluorescent intensity over conventional liposomes in the liver post spleen administration. The anti-tumor effect of various drug administration routes for both liposomal formulations was evaluated using a murine liver metastasis model of colon cancer. The results indicated that tumor progression in the liver and mesenteric lymph nodes was significantly suppressed by Dox-loaded galactosylated liposomes via spleen injection, while no significance was observed in non-targeted formulations. Our data indicated that local perfusion of galactosylated liposomal doxorubicin had a great promise for the treatment of liver metastasis from colon cancer.
languageeng
oafree_for_read
source
version8
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttps://doaj.org/article/3faf87b4fb964fb086bc3f90a91b56a8$$EView_full_text_in_DOAJ
search
creatorcontrib
0Chen Zhao
1Qiang Feng
2Zengpei Dou
3Wei Yuan
4Chenguang Sui
5Xinghua Zhang
6Guimin Xia
7Hongfang Sun
8Jie Ma
titleLocal targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin
description

Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration was substantially improved in liver as well as a decrease in blood and other organs by spleen injection mimicking portal vein perfusion (regional administration). To further investigate the targeted therapeutic effect of galactosylated liposome encapsulated doxorubicin (Dox) by regional administration, liver targeting liposomes were prepared by incorporating galactosylated-DPPE to conventional liposomes. Liposome uptake and targeting were verified in vitro and in vivo by fluorescence microscopy and xenogen IVIS imaging system, respectively. The results showed that galactose targeted liposomes presented a stronger specific cell uptake by human hepatocellular carcinoma HepG2 cells compared to the non-targeted liposomes. In vivo fluorescence imaging showed that the intra-hepatic deposition of conventional and galactosylated liposomes via spleen injection was more than that via tail vein administration, and galactosylated liposomes had higher fluorescent intensity over conventional liposomes in the liver post spleen administration. The anti-tumor effect of various drug administration routes for both liposomal formulations was evaluated using a murine liver metastasis model of colon cancer. The results indicated that tumor progression in the liver and mesenteric lymph nodes was significantly suppressed by Dox-loaded galactosylated liposomes via spleen injection, while no significance was observed in non-targeted formulations. Our data indicated that local perfusion of galactosylated liposomal doxorubicin had a great promise for the treatment of liver metastasis from colon cancer.

subjectSciences (General)
general
0English
1Public Library of Science (PLoS)
210.1371/journal.pone.0073860
3Directory of Open Access Journals (DOAJ)
sourceiddoaj_s
recordiddoaj_soai_doaj_org_article_3faf87b4fb964fb086bc3f90a91b56a8
issn
01932-6203
119326203
rsrctypearticle
addtitlePLoS ONE
searchscope
0doaj_full
1doaj1
scope
0doaj_full
1doaj1
lsr45$$EView_full_text_in_DOAJ
tmp01Directory of Open Access Journals (DOAJ)
tmp02DOA
lsr40PLoS ONE, Vol.8 (9), p.e73860
doi10.1371/journal.pone.0073860
citationpf e73860 vol 8 issue 9
lsr30VSR-Enriched:[pqid, date, galeid, pages]
sort
titleLocal targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin
authorChen Zhao ; Qiang Feng ; Zengpei Dou ; Wei Yuan ; Chenguang Sui ; Xinghua Zhang ; Guimin Xia ; Hongfang Sun ; Jie Ma
facets
frbrgroupid7818911116337497193
frbrtype5
newrecords20190714
languageeng
topicSciences (General)
collectionDirectory of Open Access Journals (DOAJ)
prefilterarticles
rsrctypearticles
creatorcontrib
0Chen Zhao
1Qiang Feng
2Zengpei Dou
3Wei Yuan
4Chenguang Sui
5Xinghua Zhang
6Guimin Xia
7Hongfang Sun
8Jie Ma
jtitlePLoS ONE
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
au
0Chen Zhao
1Qiang Feng
2Zengpei Dou
3Wei Yuan
4Chenguang Sui
5Xinghua Zhang
6Guimin Xia
7Hongfang Sun
8Jie Ma
atitleLocal targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin
jtitlePLoS ONE
volume8
issue9
spagee73860
eissn1932-6203
formatjournal
genrearticle
ristypeJOUR
abstract

Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration was substantially improved in liver as well as a decrease in blood and other organs by spleen injection mimicking portal vein perfusion (regional administration). To further investigate the targeted therapeutic effect of galactosylated liposome encapsulated doxorubicin (Dox) by regional administration, liver targeting liposomes were prepared by incorporating galactosylated-DPPE to conventional liposomes. Liposome uptake and targeting were verified in vitro and in vivo by fluorescence microscopy and xenogen IVIS imaging system, respectively. The results showed that galactose targeted liposomes presented a stronger specific cell uptake by human hepatocellular carcinoma HepG2 cells compared to the non-targeted liposomes. In vivo fluorescence imaging showed that the intra-hepatic deposition of conventional and galactosylated liposomes via spleen injection was more than that via tail vein administration, and galactosylated liposomes had higher fluorescent intensity over conventional liposomes in the liver post spleen administration. The anti-tumor effect of various drug administration routes for both liposomal formulations was evaluated using a murine liver metastasis model of colon cancer. The results indicated that tumor progression in the liver and mesenteric lymph nodes was significantly suppressed by Dox-loaded galactosylated liposomes via spleen injection, while no significance was observed in non-targeted formulations. Our data indicated that local perfusion of galactosylated liposomal doxorubicin had a great promise for the treatment of liver metastasis from colon cancer.

pubPublic Library of Science (PLoS)
doi10.1371/journal.pone.0073860
oafree_for_read
date2013
pagese73860